ロード中...
Codelivery of doxorubicin and triptolide with reduction-sensitive lipid–polymer hybrid nanoparticles for in vitro and in vivo synergistic cancer treatment
Codelivery is a promising strategy to overcome the limitations of single chemotherapeutic agents in cancer treatment. Despite progress, codelivery of two or more different functional drugs to increase anticancer efficiency still remains a challenge. Here, reduction-sensitive lipid–polymer hybrid nan...
保存先:
| 出版年: | Int J Nanomedicine |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5352248/ https://ncbi.nlm.nih.gov/pubmed/28331310 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S131235 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|